Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...
NEW HAVEN, Conn. (WTNH) — News 8 is your local election headquarters, and voting took place Tuesday in 21 communities across Connecticut. Two key races News 8 is watching are the Democratic mayoral ...
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...
CLEVELAND — Voters across Cleveland cast their ballots Tuesday night in a municipal primary that will help determine key leadership roles that could shape the city's immediate future and send ripple ...
Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...
Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...
The Kansas City Chiefs came into the 2025 NFL season with lots of question marks surrounding their offense and fantasy football prospects for the year. The team was looking to return to their previous ...
Charlotte voters will choose candidates for mayor and council in the September primary. In The Charlotte Observer’s voter guide for the election, read about Mayor Vi Lyles, the most competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback